Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

5.6%

1 terminated/withdrawn out of 18 trials

Success Rate

94.4%

+7.9% vs industry average

Late-Stage Pipeline

33%

6 trials in Phase 3/4

Results Transparency

59%

10 of 17 completed trials have results

Key Signals

10 with results

Enrollment Performance

Analytics

Phase 1
10(55.6%)
Phase 3
6(33.3%)
Phase 2
2(11.1%)
18Total
Phase 1(10)
Phase 3(6)
Phase 2(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (18)

Showing 18 of 18 trials
NCT02733367Phase 3Completed

Extension Study for Patients Entered Into Study Infacort 003

Role: lead

NCT01960530Phase 1Completed

An Investigational Study of Hydrocortisone

Role: lead

NCT05063994Phase 3Completed

Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia

Role: lead

NCT03062280Phase 3Completed

A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH

Role: lead

NCT02716818Phase 3Completed

Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia

Role: lead

NCT01735617Phase 2Completed

Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH

Role: lead

NCT02777268Phase 1Completed

Comparison of Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisone

Role: lead

NCT02720952Phase 3Completed

Treatment of Adrenal Insufficiency in Children

Role: lead

NCT03311932Phase 1Completed

A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects

Role: lead

NCT03178214Phase 1Completed

Bioavailability of Infacort When Administered Onto Food Compared to Direct Oral Administration

Role: lead

NCT02966652Phase 1Completed

Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism

Role: lead

NCT03051893Phase 1Completed

A Two-part, Study to Compare the Pharmacokinetics and Dose Proportionality of up to 6 Chronocort Formulations

Role: lead

NCT05222152Phase 2Completed

Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency

Role: lead

NCT03532022Phase 3Withdrawn

Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy

Role: lead

NCT03343327Phase 1Completed

A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects

Role: lead

NCT03019614Phase 1Completed

An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone

Role: lead

NCT02408068Phase 1Completed

Effect of Slow Release Hydrocortisone on Fed & Fasting Volunteers; Immediate Release on Fasting Only

Role: lead

NCT00519818Phase 1Completed

Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia

Role: lead

All 18 trials loaded